These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1830 related articles for article (PubMed ID: 26841800)

  • 21. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
    Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
    Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychedelics as anti-inflammatory agents.
    Flanagan TW; Nichols CD
    Int Rev Psychiatry; 2018 Aug; 30(4):363-375. PubMed ID: 30102081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Brief Historical Overview of Psychedelic Research.
    Geyer MA
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):464-471. PubMed ID: 38000715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
    de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
    ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychedelics and Psychedelic-Assisted Psychotherapy.
    Reiff CM; Richman EE; Nemeroff CB; Carpenter LL; Widge AS; Rodriguez CI; Kalin NH; McDonald WM;
    Am J Psychiatry; 2020 May; 177(5):391-410. PubMed ID: 32098487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effects of Hallucinogens on Gene Expression.
    Martin DA; Nichols CD
    Curr Top Behav Neurosci; 2018; 36():137-158. PubMed ID: 28677095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychedelic Drugs in Biomedicine.
    Kyzar EJ; Nichols CD; Gainetdinov RR; Nichols DE; Kalueff AV
    Trends Pharmacol Sci; 2017 Nov; 38(11):992-1005. PubMed ID: 28947075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beyond the 5-HT
    Cameron LP; Benetatos J; Lewis V; Bonniwell EM; Jaster AM; Moliner R; Castrén E; McCorvy JD; Palner M; Aguilar-Valles A
    J Neurosci; 2023 Nov; 43(45):7472-7482. PubMed ID: 37940583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.
    Heal DJ; Gosden J; Smith SL; Atterwill CK
    Neuropharmacology; 2023 Mar; 225():109375. PubMed ID: 36529260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Models of psychedelic drug action: modulation of cortical-subcortical circuits.
    Doss MK; Madden MB; Gaddis A; Nebel MB; Griffiths RR; Mathur BN; Barrett FS
    Brain; 2022 Apr; 145(2):441-456. PubMed ID: 34897383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD).
    Nichols DE
    ACS Chem Neurosci; 2018 Oct; 9(10):2331-2343. PubMed ID: 29461039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the 5-HT
    Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
    J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences across sexes on head-twitch behavior and 5-HT
    Jaster AM; Younkin J; Cuddy T; de la Fuente Revenga M; Poklis JL; Dozmorov MG; González-Maeso J
    Neurosci Lett; 2022 Sep; 788():136836. PubMed ID: 35963476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression.
    Delli Pizzi S; Chiacchiaretta P; Sestieri C; Ferretti A; Onofrj M; Della Penna S; Roseman L; Timmermann C; Nutt DJ; Carhart-Harris RL; Sensi SL
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2023 Jul; 8(7):768-776. PubMed ID: 37003409
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The promises and perils of psychedelic pharmacology for psychiatry.
    McClure-Begley TD; Roth BL
    Nat Rev Drug Discov; 2022 Jun; 21(6):463-473. PubMed ID: 35301459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].
    Majić T; Jungaberle H; Schmidt TT; Zeuch A; Hermle L; Gallinat J
    Fortschr Neurol Psychiatr; 2017 Jul; 85(7):383-392. PubMed ID: 28768346
    [No Abstract]   [Full Text] [Related]  

  • 38. Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.
    Halberstadt AL
    Behav Brain Res; 2015 Jan; 277():99-120. PubMed ID: 25036425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.
    Garcia-Romeu A; Richards WA
    Int Rev Psychiatry; 2018 Aug; 30(4):291-316. PubMed ID: 30422079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No trip needed for psychedelics to lift mood?
    O'Grady C
    Science; 2023 Jun; 380(6649):999. PubMed ID: 37289868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 92.